Shadfar Bahri

2.5k total citations · 2 hit papers
31 papers, 1.9k citations indexed

About

Shadfar Bahri is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Shadfar Bahri has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Shadfar Bahri's work include Medical Imaging Techniques and Applications (11 papers), MRI in cancer diagnosis (8 papers) and Breast Cancer Treatment Studies (6 papers). Shadfar Bahri is often cited by papers focused on Medical Imaging Techniques and Applications (11 papers), MRI in cancer diagnosis (8 papers) and Breast Cancer Treatment Studies (6 papers). Shadfar Bahri collaborates with scholars based in United States, Taiwan and Japan. Shadfar Bahri's co-authors include Min‐Ying Su, Hartmuth C. Kolb, Anna Katrin Szardenings, Joseph C. Walsh, Fanrong Mu, William R. Shankle, David Chien, Arkadij M. Elizarov, Jeon‐Hor Chen and Orhan Nalcioğlu and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Radiology.

In The Last Decade

Shadfar Bahri

30 papers receiving 1.8k citations

Hit Papers

Early Clinical PET Imaging Results with the Novel PHF-Tau... 2013 2026 2017 2021 2013 2013 100 200 300 400 500

Peers

Shadfar Bahri
Jae‐Hoon Lee South Korea
Shadfar Bahri
Citations per year, relative to Shadfar Bahri Shadfar Bahri (= 1×) peers Jae‐Hoon Lee

Countries citing papers authored by Shadfar Bahri

Since Specialization
Citations

This map shows the geographic impact of Shadfar Bahri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shadfar Bahri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shadfar Bahri more than expected).

Fields of papers citing papers by Shadfar Bahri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shadfar Bahri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shadfar Bahri. The network helps show where Shadfar Bahri may publish in the future.

Co-authorship network of co-authors of Shadfar Bahri

This figure shows the co-authorship network connecting the top 25 collaborators of Shadfar Bahri. A scholar is included among the top collaborators of Shadfar Bahri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shadfar Bahri. Shadfar Bahri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hotta, Masatoshi, Andrea Farolfi, Tristan Grogan, et al.. (2024). FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging. 51(11). 3373–3385. 3 indexed citations
2.
Tatekawa, Hiroyuki, Hiroyuki Uetani, Akifumi Hagiwara, et al.. (2021). Preferential tumor localization in relation to 18F-FDOPA uptake for lower‐grade gliomas. Journal of Neuro-Oncology. 152(3). 573–582. 3 indexed citations
3.
Calais, Jérémie, Johannes Czernin, Pan Thin, et al.. (2021). Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312). Journal of Nuclear Medicine. 62(10). 1447–1456. 29 indexed citations
4.
Virgolini, Irene, Shadfar Bahri, Andreas Kjær, et al.. (2021). A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for 68Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors. Journal of Nuclear Medicine. 63(3). 376–383. 5 indexed citations
6.
Tatekawa, Hiroyuki, Hiroyuki Uetani, Akifumi Hagiwara, et al.. (2021). Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden. Annals of Nuclear Medicine. 35(9). 1022–1029. 5 indexed citations
7.
Hotta, Masatoshi, Ida Sonni, Matthias Benz, et al.. (2021). 68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3736–3737. 16 indexed citations
9.
Tatekawa, Hiroyuki, Akifumi Hagiwara, Hiroyuki Uetani, et al.. (2020). Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas. Journal of Neuro-Oncology. 149(2). 337–346. 6 indexed citations
10.
Parikh, Neil R., Carol J. Bennett, Michael Lewis, et al.. (2020). The Impact of 18F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer. Advances in Radiation Oncology. 5(6). 1364–1369. 6 indexed citations
11.
Chen, Jeon‐Hor, Li‐Kuang Chen, Chih‐Kai Chang, et al.. (2013). Effect of taxane‐based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR. NMR in Biomedicine. 26(12). 1705–1713. 9 indexed citations
13.
Chang, Daniel, Jeon‐Hor Chen, Muqing Lin, et al.. (2011). Comparison of breast density measured on MR images acquired using fat‐suppressed versus nonfat‐suppressed sequences. Medical Physics. 38(11). 5961–5968. 27 indexed citations
14.
Chen, Jeon‐Hor, Shadfar Bahri, Rita S. Mehta, et al.. (2011). Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging. Radiology. 261(3). 735–743. 63 indexed citations
15.
Chen, Jeon‐Hor, Ke Nie, Shadfar Bahri, et al.. (2010). Decrease in Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy: MR Imaging Evaluation. Radiology. 255(1). 44–52. 34 indexed citations
16.
Bahri, Shadfar, et al.. (2009). Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis. Clinical Drug Investigation. 29(11). 713–719. 2 indexed citations
17.
Baek, Hyeon-Man, Jeon‐Hor Chen, Ke Nie, et al.. (2009). Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative1H MR Spectroscopy. Radiology. 251(3). 653–662. 108 indexed citations
18.
Chen, Jeon‐Hor, David Hsiang, John Butler, et al.. (2009). Impact of MRI-Evaluated Neoadjuvant Chemotherapy Response on Change of Surgical Recommendation in Breast Cancer. Annals of Surgery. 249(3). 448–454. 36 indexed citations
19.
Bahri, Shadfar, Rita S. Mehta, Philip M. Carpenter, et al.. (2009). Residual Breast Cancer Diagnosed by MRI in Patients Receiving Neoadjuvant Chemotherapy with and Without Bevacizumab. Annals of Surgical Oncology. 16(6). 1619–1628. 61 indexed citations
20.
Nie, Ke, Jeon‐Hor Chen, Si‐Wa Chan, et al.. (2008). Development of a quantitative method for analysis of breast density based on three‐dimensional breast MRI. Medical Physics. 35(12). 5253–5262. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026